Health Care Select Sector SPDR (XLV)

Add to Watchlists
Create an Alert
62.81 -0.43  -0.68% NYSE Arca Oct 2, 12:28PM BATS Real time Currency in USD
View Full Chart
XLV Price Chart

XLV Description

Health Care Select Sector SPDR is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Health Care Select Sector TR USD index and has 11.05B USD assets under management. It has an expected distribution yield of 1.41%, a Forecasted PE Ratio of 19.88, and a Forecasted Price to Book Value of 3.472. The fund has a net expense ratio of 0.16%, turns over its positions 5.43% per year, and is traded on the New York Stock Exchange Arca.

Benchmark Index: S&P Health Care Select Sector TR USD

XLV Key Info

Expense Ratio (1-31-14) 0.16%
Assets Under Management (10-1-14) 11.05B
30-Day Average Volume (10-1-14) 6.264M
Net Asset Value (10-1-14) 63.27
Discount or Premium to NAV (10-1-14) -0.05%
Turnover Ratio (9-30-13) 5.43%

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.03% 0.03% 0.00%
Stock 99.97% 99.97% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 29, 2014

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Sept. 19, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.26%
Industrials 0.00%
Real Estate 0.00%
Technology 0.74%
Utilities 0.00%
As of Sept. 29, 2014

XLV Stock Market Capitalization

Giant 60.23%
Large 34.48%
Medium 5.25%
Small 0.00%
Micro 0.00%
As of Sept. 29, 2014
View More Holdings

XLV Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 12.21% 103.68 -0.59%
Pfizer Inc 7.67% 29.01 -0.48%
Merck & Co Inc 6.96% 58.59 -0.20%
Gilead Sciences Inc 6.60% 104.55 -0.98%
Amgen Inc 4.32% 137.10 -1.24%
AbbVie Inc 3.78% 56.33 -1.57%
Bristol-Myers Squibb Company 3.50% 50.06 -0.93%
UnitedHealth Group Inc 3.44% 84.31 -0.67%
Biogen Idec Inc 3.24% 318.77 -1.46%
Celgene Corp 3.11% 91.78 -1.77%
As of Sept. 29, 2014
Get Quote for
Advertisement

XLV Risk Info

Beta 0.7077
30 Day Average Volatility 10.73%

XLV Fundamentals

Dividend Yield TTM (10-2-14) 1.41%
Weighted Average PE Ratio 24.37
Weighted Average Price to Sales Ratio 1.911
Weighted Average Price to Book Ratio 3.918
Weighted Median ROE 20.95%
Weighted Median ROA 9.15%
Forecasted Dividend Yield 1.55%
Forecasted PE Ratio 19.88
Forecasted Price to Sales Ratio 1.844
Forecasted Price to Book Ratio 3.472
Number of Holdings 55.00
As of Sept. 29, 2014

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.79%
Forecasted Book Value Growth 9.04%
Forecasted Cash Flow Growth 1.34%
Forecasted Earnings Growth 5.50%
Forecasted Revenue Growth 7.81%
As of Sept. 29, 2014

XLV Performance

  Returns Total Returns
1M -1.64% -1.29%
3M 1.96% 2.33%
6M 6.72% 7.50%
1Y 22.60% 24.44%
3Y 97.95% 109.0%
5Y 122.3% 144.0%
As of Oct. 1, 2014

XLV Flows

1M 219.12M
3M 505.31M
6M 734.99M
YTD 1.204B
1Y 1.562B
3Y 2.488B
5Y 4.470B
As of Sept. 30, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.